The FDA announced on 2014-10-24 that Hospira Inc. is recalling Meropenem I.V. Injection Vials due to a defective container hazard. Glass vials may crack, leading to contamination and lack of assurance of sterility.
How to tell if you have it
- Brand: Hospira
- Product: Meropenem I.V. Injection Vials (1 g in 30 mL)
- NDC: 0409-3506-01
- Lot codes: 609E014, 609E015, 609E016, 609E017, 609E018, 609E019, 601E025, 601E027, 601E028A, 601E028B, 601E028C
- Expiration dates: 1/2016 or 1J/2016
- Units affected: 261,706 vials
The hazard
The glass vials may crack due to low out of specification vial wall thickness. This defect may lead to contamination and lack of assurance of sterility.
Context
GovInfoNow's records show Hospira Inc. has 108 other recalls on record since 2012-04-05. Other recent recalls include the 2017-04-21 Hospira Infant Dextrose Injection Recall for hair particulates, the 2016-11-01 Hospira Fentanyl Injection Recall for broken ampule tips, and the 2016-08-15 Hospira DOBUTamine Injection Recall for discoloration. Other recent recalls of similar products include Thea Pharma Similasan Eye Drops (2026-04-23), Chies CUROSURF (2026-03-17), and Dabur Cura Hongos Antifungal Tubes (2026-06-02).